Clinical Trial Update: Long Acting Neuraxial Peri-prostatic Block in Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for a long-acting neuraxial peri-prostatic block in cancer targeting prostate cancer; the trial is currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Prostate Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING